Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Sep 29, 2026.
Notices with a clearly misreported market value (for example billions of dollars for a few thousand shares) are left out of this list and its totals. They still appear, flagged, on the company's page.
- Notices
- 16
- Market value to sell
- $126.7M
- Sellers
- 6
- Companies
- 1
- Under 10b5-1 plans
- 13
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| CNTACentessa Pharmaceuticals plc | Mar 26, 20264:22 PM ET | Weinhoff Gregory MOfficer | 24.0K | $675.5K | Mar 26, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Mar 26, 20264:05 PM ET | Anderson Karen M.Officer | 41.1K | $1.16M | Mar 26, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Mar 17, 20264:02 PM ET | Anderson Karen M.Officer | 10.0K | $281.0K | Mar 17, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Mar 16, 20264:24 PM ET | Anderson Karen M.Officer | 64.8K | $1.83M | Mar 16, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Mar 13, 20265:05 PM ET | Anderson Karen M.Officer | 120.0K | $3.10M | Mar 13, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Mar 13, 20264:09 PM ET | Weinhoff Gregory MOfficer | 73.2K | $1.99M | Mar 13, 202610b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Jan 30, 20264:29 PM ET | Iqbal HussainOfficer | 40.0K | $1.02M | Jan 30, 2026 | UBS Financial Services Inc | SEC |
| CNTACentessa Pharmaceuticals plc | Jan 21, 20264:58 PM ET | Saurabh SahaFormer officer | 2.30M | $52.6M | Jan 21, 2026 | UBS Financial Services Inc | SEC |
| CNTACentessa Pharmaceuticals plc | Jan 2, 20264:45 PM ET | Saurabh SahaPrevious Officer | 2.50M | $60.8M | Jan 2, 2026 | UBS Financial Services Inc | SEC |
| CNTACentessa Pharmaceuticals plc | Dec 9, 20254:39 PM ET | Accardi Mario AlbertoOfficer | 10.0K | $293.0K | Dec 9, 202510b5-1 | UBS Financial Services, Inc | SEC |
| CNTACentessa Pharmaceuticals plc | Dec 8, 20254:06 PM ET | Accardi Mario AlbertoOfficer | 10.0K | $300.0K | Dec 8, 202510b5-1 | UBS Financial Services, Inc | SEC |
| CNTACentessa Pharmaceuticals plc | Nov 17, 20254:03 PM ET | Bush Tia LOfficer | 40.0K | $1.12M | Nov 17, 202510b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Nov 17, 20254:01 PM ET | Hussain Iqbal JOfficer | 6.00K | $166.4K | Nov 17, 202510b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Nov 12, 20254:05 PM ET | Bush Tia LOfficer | 40.0K | $1.04M | Nov 12, 202510b5-1 | UBS Financial Services Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Oct 27, 20255:31 PM ETAmended | Accardi Mario AlbertoOfficer | 8.00K | $200.0K | Oct 27, 202510b5-1 | UBS Financial Services, Inc. | SEC |
| CNTACentessa Pharmaceuticals plc | Oct 15, 20254:17 PM ET | Hussain Iqbal JOfficer | 6.00K | $135.7K | Oct 15, 202510b5-1 | UBS Financial Services Inc. | SEC |